The appeals under consideration address the legitimacy of the Notification issued pursuant to Section A of the Drugs and Cosmetics Act by the Ministry of Health and Family Welfare This ... notification limits the production of Oxytocin formulations for domestic use exclusively to public sector entities while allowing both sectors to manufacture for export with the enforcement date initially set and later extended